Page last updated: 2024-12-10

15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, (s)-(e,z,z,z)-isomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 15-Hydroperoxy-5,8,11,13-eicosatetraenoic acid (s)-(e,z,z,z)-isomer: A Key Player in Inflammation and Beyond

**15-Hydroperoxy-5,8,11,13-eicosatetraenoic acid (15-HPETE)** is a crucial lipid mediator that plays a significant role in various biological processes, especially **inflammation**, making it a cornerstone for researchers in various fields. Let's break down the compound and its significance:

**What it is:**

* **15-HPETE:** A fatty acid derivative of arachidonic acid.
* **Hydroperoxy:** Contains a peroxide group (-OOH) at the 15th carbon.
* **(s)-(e,z,z,z)-isomer:** This specific isomer refers to the configuration of the double bonds and the chiral center.
* **(s):** The chiral center at carbon 15 has a specific stereochemical configuration.
* **(e,z,z,z):** Refers to the configuration of the double bonds, with 'e' denoting a trans (opposite) configuration and 'z' denoting a cis (same) configuration.

**Why it is important:**

**1. Inflammation:** 15-HPETE is a key intermediate in the **arachidonic acid cascade**, a complex signaling pathway leading to the production of various inflammatory mediators like **leukotrienes**, **prostaglandins**, and **thromboxanes**. These mediators are involved in diverse inflammatory responses, from pain and swelling to immune cell recruitment. Understanding the role of 15-HPETE in this pathway is critical for developing **anti-inflammatory drugs**.

**2. Vascular Biology:** 15-HPETE contributes to **vasoconstriction**, narrowing blood vessels. This effect can impact blood pressure and potentially contribute to cardiovascular disease.

**3. Cancer:** 15-HPETE has been implicated in **cancer cell proliferation** and **angiogenesis**, the formation of new blood vessels that supply tumors. Research aims to uncover the specific mechanisms of 15-HPETE's involvement in cancer development and explore its potential as a **therapeutic target**.

**4. Nervous System:** 15-HPETE plays a role in **neurotransmission** and **neuroprotection**. Some studies suggest it can modulate neuronal activity and influence the central nervous system.

**5. Other research areas:** 15-HPETE is also being investigated for its roles in:
* **Immune system regulation:** modulating immune cell responses.
* **Wound healing:** impacting the healing process.
* **Asthma:** contributing to airway inflammation.

**Research focus:**

Scientists are actively investigating:

* **Metabolic pathways:** How 15-HPETE is synthesized and metabolized.
* **Cellular signaling:** How 15-HPETE interacts with specific receptors and triggers downstream signaling events.
* **Therapeutic potential:** Exploring 15-HPETE as a target for drug development.

**In summary:** 15-HPETE (s)-(e,z,z,z)-isomer is a crucial lipid mediator with diverse biological functions, particularly in inflammation. Its role in various physiological processes makes it a significant target for research in areas like medicine, biology, and pharmacology, offering potential avenues for developing new therapies and improving our understanding of human health.

HPETE : Mono-hydroperoxy (e)icosatetraenoic acids (HPETEs) are the primary products of lipoxygenase-catalysed oxygenation of arachidonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

15(S)-HPETE : The (S)-enantiomer of 15-HPETE. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5280893
CHEMBL ID1606580
CHEBI ID15628
SCHEMBL ID4329512
MeSH IDM0316139

Synonyms (51)

Synonym
70981-96-3
7bn3o939p6 ,
15-hpete, (s)-
(s-(e,z,z,z))-15-hydroperoxy-5,8,11,13-eicosatetraenoic acid
unii-7bn3o939p6
5,8,11,13-eicosatetraenoic acid, 15-hydroperoxy-, (s-(e,z,z,z))-
gtpl2482
(5z,8z,11z,13e,15s)-15-hydroperoxyicosa-5,8,11,13-tetraenoic acid
15s-hpete
CHEBI:15628 ,
LMFA03060014
15s-hydroperoxy-5z,8z,11z,13e-eicosatetraenoic acid
IDI1_033809
15-hydroperoxyicosatetraenoate
(5z,8z,11z,13e)-(15s)-15-hydroperoxyicosa-5,8,11,13-tetraenoate
15(s)-hpete
(5z,8z,11z,13e)-(15s)-15-hydroperoxyicosa-5,8,11,13-tetraenoic acid
15-hydroperoxyeicosatetraenoate
C05966
15-hydroperoxyeicosatetraenoic acid
15-hydroperoxyicosatetraenoic acid
15(s)-hydroperoxy-(5z,8z,11z,13e)-eicosatetraenoic acid, ~100 mug/ml in ethanol, >=95%
NCGC00161251-02
NCGC00161251-01
BSPBIO_001339
NCGC00161251-03
HMS1989C21
BML1-C06
HMS1361C21
HMS1791C21
SCHEMBL4329512
bdbm50025742
chembl1606580 ,
(s)-15-hydroperoxy-icosa-5,8,11,13-tetraenoic acid(15(s)-ooh-20 : 4)
5,8,11,13-eicosatetraenoicacid, 15-hydroperoxy-, (5z,8z,11z,13e,15s)-
15(s)-hydroperoxy-(5z,8z,11z,13e)-eicosatetraenoic acid
BFWYTORDSFIVKP-VAEKSGALSA-N
hpete
15-hydroperoxyeicosatetraenoic acid, (5z,8z,11z,13e,15s)-
5,8,11,13-eicosatetraenoic acid, 15-hydroperoxy-, (5z,8z,11z,13e,15s)-
(5z,8z,11z,13e,15s)-15-hydroperoxy-5,8,11,13-eicosatetraenoic acid
15-hydroperoxyarachidonic acid, (s)-
HMS3402C21
15s-hydroperoxyeicosatetraenoic acid
15s-hydroperoxyeicosatetraenoate
5,8,11,13-eicosatetraenoicacid,15-hydroperoxy-,(5z,8z,11z,13e,15s)-
(s)-15-hpete
Q27070784
15(s)-hpete lipid maps(r) ms standard
DTXSID301318203
AKOS040754944
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
15-HPETEA HPETE that consists of (5Z,8Z,11Z,13E)-icosatetraenoic acid in which the hydroperoxy group is located at position 15.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (51)

PathwayProteinsCompounds
Metabolism14961108
Metabolism of lipids500463
Fatty acid metabolism113203
Arachidonic acid metabolism3682
Synthesis of 15-eicosatetraenoic acid derivatives314
Biosynthesis of specialized proresolving mediators (SPMs)13107
Synthesis of Lipoxins (LX)616
Arachidonic Acid Metabolism2966
Leukotriene C4 Synthesis Deficiency2966
Piroxicam Action Pathway2967
Acetylsalicylic Acid Action Pathway2967
Etodolac Action Pathway2967
Ketoprofen Action Pathway2967
Ibuprofen Action Pathway5076
Rofecoxib Action Pathway2967
Diclofenac Action Pathway2967
Sulindac Action Pathway2967
Celecoxib Action Pathway3573
Ketorolac Action Pathway2967
Suprofen Action Pathway2967
Bromfenac Action Pathway2967
Indomethacin Action Pathway3067
Mefenamic Acid Action Pathway2967
Oxaprozin Action Pathway2967
Nabumetone Action Pathway2967
Naproxen Action Pathway2967
Diflunisal Action Pathway2967
Meloxicam Action Pathway2967
Valdecoxib Action Pathway2967
Antipyrine Action Pathway2967
Antrafenine Action Pathway2967
Carprofen Action Pathway2967
Etoricoxib Action Pathway2967
Fenoprofen Action Pathway2967
Flurbiprofen Action Pathway2967
Magnesium Salicylate Action Pathway2967
Lumiracoxib Action Pathway2967
Lornoxicam Action Pathway2967
Phenylbutazone Action Pathway2967
Nepafenac Action Pathway2967
Trisalicylate-Choline Action Pathway2967
Tolmetin Action Pathway2967
Tiaprofenic Acid Action Pathway2967
Tenoxicam Action Pathway2967
Salsalate Action Pathway2967
Salicylate-Sodium Action Pathway2967
Salicylic Acid Action Pathway2967
Acetaminophen Action Pathway2967
Prostaglandin and Leukotriene metabolism ( Prostaglandin and Leukotriene metabolism )2223
Eicosanoid metabolism via lipooxygenases (LOX)040
Eicosanoid metabolism via lipoxygenases (LOX)040
Eicosanoid synthesis026

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
regulator of G-protein signaling 4Homo sapiens (human)Potency18.88760.531815.435837.6858AID504845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)IC50 (µMol)3.40000.00462.018210.0000AID6794
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID6794Inhibition of rat basophilic leukemia-1 (RBL-1) 5-lipoxygenase1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Structural requirements for the inhibition of 5-lipoxygenase by 15-hydroxyeicosa-5,8,11,13-tetraenoic acid analogues.
AID1346643Rat TRPV1 (Transient Receptor Potential channels)2000Proceedings of the National Academy of Sciences of the United States of America, May-23, Volume: 97, Issue:11
Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.92 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]